MedTrace Logo

SpO2 Data Collection in Pediatric Patients Using INVSENSOR00061

NCT05896267 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2025-11-12

Study results available
· View outcomes & findings →

Summary

This is a prospective, non-randomized data collection study to evaluate the form, fit, and function of INVSENSOR00061.

Conditions

  • Spo2

Interventions

DEVICE

Masimo INVSENSOR00061

Masimo INVSENSOR00061 will be used to measure noninvasive SpO2 (Oxygen Saturation )

Sponsors & Collaborators

  • Masimo Corporation

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
37 Weeks
Max Age
18 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-15
Primary Completion
2023-06-22
Completion
2023-06-22
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05896267 on ClinicalTrials.gov